Melissa Johnson
@idpharmacist
Prof of Medicine DUMC; Liaison @DASON_duke; Past-President @SIDPharm 2023-2024 | Infectious Diseases/ASP/Mycology #IDTwitter | views own | she/her
ID: 185660584
https://www.researchgate.net/profile/Melissa-Johnson-46 01-09-2010 14:44:29
6,6K Tweet
4,4K Followers
2,2K Following
Providers find it difficult not to treat once they have a positive U/A or UCx, independent of whether it was appropriate to test and when they know the evidence doesn’t show a benefit in treating asymptomatic bacteriuria. Goal needs to be reducing testing. academic.oup.com/ofid/advance-a…
Retrospective review of a very challenging clinical entity, candida prosthetic joint infections, now in Clinical Infectious Diseases. Debridement, antibiotics, and implant retention assoc with lower rates of cure c/w 1- or 2-stage exchange. doi.org/10.1093/cid/ci…
Nothing to see over here, just me becoming besties with the amazing ID pharmacists Washington University ID Division. Like I always say, an ID pharmacist is an ID attending’s attending.
What a wonderful team to work with! I had such fun and learned so much debating fungal diagnostics and treatment strategies with amazing international experts monica slavin and Oliver Cornely at the MSGERC Biennial Meeting. #MSGERC2024
Who is that guy? Another excellent session from #MSGERC2024 with Melissa Johnson Melissa Johnson on antifungal TDM and David Boulware David Boulware, MD MPH on single dose AmB vs crypto meningitis. Fantastic discussion session afterwards, as for every session here.
Fantastic talks & moderation this week MSGERC. Great new information from Neil Clancy & David Boulware, MD MPH on ocular manifestations of candidiasis and applications of high single dose LAmB, expertly moderated by Dr. Hong Nguyen. Looking forward to seeing additional work on this!